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The in vivo 31p NMR spectrum of T47D human breast cancer cells grown as spheroids hows changes in the phosphomonoester lipid precursors 
as a function of spheroid size. The ratio of phosphorylethanolamine (PE) to phosphorylcholine (PC) was 1.0_ 0.3 for 3-day-old, 150 tan spheroids. 
This ratio increased to 2.4+0.4 for spheroids 7days and older and which were at least 300/tm in diameter. To investigate he phosphatidylethanol- 
amine to phosphatidylcholine (PdylE/PdylC) ratio in the membranes, chloroform/methanol extracts of spheroids were performed. The 31p spectrum 
of these extracts howed no change with spheroid size, namely the PdylE/PdylC ratio was 0.55-0.06 for spheroids of all ages suggesting that 
membrane composition is strongly regulated at the precursor level. 
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1. INTRODUCTION 
Increasingly, magnetic resonance imaging (MRI) and 
magnetic resonance spectroscopy (MRS) are being used 
for in vivo tumor detection and diagnosis in humans 
([1] and references therein). Concomitantly laboratory 
studies of transformed cells in culture and implanted 
tumors in animals trive to determine the characteristics 
of cancer by nuclear magnetic resonance (NMR) spec- 
troscopy ([1] and references therein). In general, the 
NMR spectrum of tumors during growth shows a 
decreasing level of energy-rich compounds such as NTP 
and phosphocreatine, and an increasing level of Pi and 
the phosphomonoesters (PME) composed of phos- 
phorylethanolamine (PE) and phosphorylcholine (PC). 
It is also possible to monitor the effects of different 
modes of cancer treatment such as chemotherapeutic 
agents ([2] and references therein), cytokines ([3] and 
references therein) radiation ([4] and references therein) 
and others, on cells in culture- and animal-implanted 
tumors as well as human patients. The observed 
changes in the 3Xp NMR spectrum as a consequence of 
treatment have often been shown to be a reversal of the 
trends observed uring untreated tumor progression, 
namely a decrease in the PME levels and an increase in 
the ATP/Pi ratio. 
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Multicellular tumor spheroids, constitute an excellent 
model for tumor behavior in vivo ([5] and references 
therein). These mini-tumors, which can be grown under 
controlled laboratory conditions up to an average size 
of 700/zm in T47D cells, present he same charac- 
teristics as an in vivo tumor. As the spheroid size in- 
creases, only its external (ca 50/~m) layer of cells will re- 
main in the proliferating state while the more internal 
layers will be in a quiescent and then necrotic state 
similarly to less vascularized regions of the tumor. 
Our work is involved in the study of T47D clone 11 
human breast cancer cells grown as spheroids. We have 
been able to introduce these spheroids into the NMR by 
encapsulating them in agarose beads and we can main- 
tain them in a proliferating state inside the spectrometer 
as previously described [6]. Under these conditions we 
have been able to monitor variations in spheroid 
metabolism as a function of spheroid size. In par- 
ticular, we have concentrated onvariations in the PME 
region belonging to the water-soluble ipid precursors 
namely changes in phosphorylcholine and phosphoryl- 
ethanolamine. The latter are precursors of phospha- 
tidylcholine and phosphatidylethanolamine, respective- 
ly. Phosphatidylcholine is synthesized primarily 
through the CDP-choline route (Kennedy pathway) [7], 
using choline as a precursor which is phosphorylated to 
phosphorylcholine, converted to CDP-choline and 
combined with a diacylglycerol to form the membrane 
lipid. Phoshatidylethanolamine sy thesis on the other 
hand is performed through either of 3 possible 
pathways. (i) The CDP-ethanolamine pathway, 
analogous to the CDP-choline route, through phos- 
phorylethanolamine and CDP-ethanolamine [8]. (ii) 
The decarboxylation of phosphatidylserine [9]: this 
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pathway requires catalytic amounts of ethanolamine 
and generates more ethanolamine by formation of 
phosphatidylserine from phosphatidylethanolamine 
thus liberating ethanolamine. This is followed by 
phosphatidylserine d carboxylation to yield again 
phosphatidylethanolamine. Th  ethanolamine formed 
in this fashion is incorporated into phosphatidyletha- 
nolamine through the CDP-ethanolamine route. (iii) 
The calcium-dependent xchange of free ethanolamine 
for the head group moiety of phosphatidylserine [10]. 
We show here, that the PE/PC ratio in T47D 
spheroids increased uring active spheroid growth and 
cell division, then leveled off when the spheroids had 
reached the size at which necrosis commenced. 
However, the cell membrane composition of these 
spheroids howed no modification with growth and the 
PdylE/PdylC ratio remained constant along the growth 
curve. 
2. MATERIALS AND METHODS 
T47D clone 11 human breast cancer cells were obtained from the 
pleural effusion of infiltrating duct carcinoma [11] and were a gift 
from Prof. I. Keydar (Tel-Aviv University). 
Spheroids were prepared and introduced into the NMR following 
encapsulation in agarose beads as previously described [6]. 
Spheroid cell membrane components were obtained by a 
chloroform/methanol extract based on the method outlined by Bligh 
and Dyer [12]. The lipid containing chloroform phase was lyophilized 
and redissolved in a CDCl3/methanol/D20 mixture at a ratio of 
8:4 : 1, and containing 15 mM CsEDTA as described by Meneses and 
Glonek [13]. 
The nuclear magnetic resonance experiments were performed on a 
Bruker AM-500 spectrometer, quipped with a quadro-nuclei (~5N, 
~3C, 3~p, ~H) software-controlled probe. 3~p spectra were recorded at 
202.5 MHz by applying a 90 ° pulse, 10 s repetition delay and com- 
posite pulse proton decoupling. The in vivo spectra were recorded at 
(35 ±2)°C. The cells were perfused inside the NMR probe with a 
sterile perfusion system previously described [14]. 31p peak areas were 
obtained by fitting the in vivo spectra obtained uring the first 2 h of 
the experiment and plotted at a line broadening of 25 Hz to a set of 
Lorentzian lines using the Bruker Glinfit program. The 31p spectra of 
the membrane extracts were recorded at (0 ± 2)°C with the same spec- 
tral parameters a above. These peak areas were obtained using the 
Bruker Glinfit program and fitting to spectra plotted with no line 
broadening. 
3. RESULTS AND DISCUSSION 
The phosphomonoester r gion of T47D clone 11 
human breast cancer cells grown as spheroids changed 
markedly as a function of spheroid age and size; this is 
demonstrated in Fig. 1. Here we show 3 typical spectra, 
acquired uring the first 2 h subsequent tointroduction 
into the spectrometer, for spheroids 3 days (100/zm in 
diameter), 6 days (200/zm in diameter), and 21 days 
(350 /zm in diameter) after seeding. The primary 
changes how a marked increase in PE and a slight 
decrease in PC with spheroid growth, while GPC and 
GPE remained, within experimental error, constant. 
This is further demonstrated in Fig. 2. Here we show 
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Fig. 1.31p spectra of spheroids 3, 6 and 21 days old. Each spectrum 
is the result of 180 fully relaxed transients (90 ° and 10 s relaxation 
delay) plotted with a line broadening of25 Hz. Average spheroid size, 
determined by light microscope, is plotted schematically. 
the ratio of phosphorylethanolamine to phosphoryl- 
choline as a function of spheroid age. Starting at a value 
of 1.0_+0.3 for 3-day-old spheroids, the PE/PC ratio 
shows an initial increase. At this stage the spheroids are 
composed of a homogenous population of actively pro- 
liferating and dividing cells. The PE/PC ratio then 
leveled off at about 7 days at a value of 2.4_+0.4. 
Earlier studies performed in our laboratory [6] showed 
that 7 days is the time which correlates with the onset of 
necrosis in T47D spheroids and a subsequent decrease 
in cell division, at this point the spheroids are composed 
of proliferating, quiescent and necrotic ells. 
Since the 31p spectrum showed that the lipid precur- 
sor pool sizes change with spheroid age, the question 
arose as to how this affected the membrane components 
themselves, namely the PdylE/PdylC ratio. We in- 
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Fig. 2. Plot of phosphorylethanolamine to phosphorylcholine area 
ratio as a function of time from spheroid seeding. Error bars repre- 
sent the error in areas calculated using the Bruker Glinfit program. 
Results were fit to an exponential curve. 
148 
Volume 266, number 1,2 FEBS LETTERS June 1990 
Phosphalid Icholine 
Doys PdylP" / PClylC 
3 0.4 
3 0,5 
Phospha tidylet ho nol ornine 7 0.5 
114 I 0.5 
21 0.4 
i:o oto -,:o -2:o -37o 
ppm 
Fig. 3. 3~p spectrum of the chloroform phase obtained from a 
methanol/chloroform extract of 14-day-old spheroids. Spectrum was 
obtained as described insection 2following 70 scans and plotted with 
a line broadening of 5 Hz. The two signals between the lipids are due 
to phosphatidylinositol and lysophosphatidylcholine [ 13]. The table is 
a summary of phosphatidylethanolamine to phosphatidyleholine ar a 
ratios ( + 20%) presented as a function of the extracted spheroid age. 
3 + 2 represents the extraction of spheroids grown three days in the in- 
cubator and two days in the NMR spectrometer. 
phosphorylchol ine cytidyltransferase step could be 
faster for the larger spheroids leading to a reduced PC 
pool size. In addition, PC can also be the product of  
phosphatidylcholine breakdown by phospholipase C
[15], and thus the regulation of  its pool size can be 
dependent on membrane breakdown. The synthesis rate 
o f  phosphatidylethanolamine through either of  the 3 
pathways earlier described (CDP-ethanolamine path- 
way, phosphatidylserine decarboxylation or serine- 
ethanolamine exchange) might be modified with growth 
to cause accumulation of  PE, We are in the process of  
investigating these issues by following the incorporation 
of  the ~3C-labeled lipid precursors, choline, ethanol- 
amine and serine, into the membrane and their subse- 
quent breakdown. In this fashion we hope to clarify the 
reasons for the variations in phosphorylethanolamine 
to phosphorylchol ine ratio with spheroid age and size as 
well as the stage at which membrane composit ion is 
controlled. Furthermore this might explain changes 
observed in PME composit ion during tumor growth in 
vivo. 
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